Epstein–Barr virus-positive mucocutaneous ulcer in Crohn's disease. A condition to consider in immunosuppressed IBD patients

Digestive and Liver Disease

Volumn 49, Issue 8, 2017, Pages 934-937

  Juan, Alba ^a   Lobatón, Triana ^a   Tapia, Gustavo ^a   Mañosa, Míriam ^a,b   Cabré, Eduard ^a,b   Domènech, Eugeni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Crohn's disease; EBV mucocutaneous ulcer; Infliximab

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; INFLIXIMAB; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANUS FISTULA; ARTICLE; CASE REPORT; COLONOSCOPY; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM ULCER; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; EPSTEIN-BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; INTESTINE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECTOSCOPY; RECTUM RESECTION; RECTUM ULCER; RISK FACTOR; TENESMUS; WEIGHT REDUCTION; COMPLICATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; RECTUM; SURGERY; ULCER; VIROLOGY;

ADULT; COLONOSCOPY; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPROLIFERATIVE DISORDERS; MALE; PROCTOSCOPY; RECTUM; ULCER;

EID: 85018919030     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2017.03.011     Document Type: Article

References (10)

1. Moran, N.R., Webster, B., Lee, K.M., et al. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease. World Journal of Gastroenterology 21 (2015), 6072–6076.
2. McGinness, J.L., Spicknall, K.E., Mutasim, D.F., Azathioprine-induced EBV-positive mucocutaneous ulcer. Journal of Cutaneous Pathology 39 (2012), 377–381.
3. Swerdlow, S.H., Campo, E., Pileri, S.A., et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 (2016), 2375–2390.
4. Dojcinov, S.D., Venkataraman, G., Raffeld, M., et al. EBV positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. American Journal of Surgical Pathology 34 (2010), 405–417.
5. Roberts, T., Chen, X., Liao, J., Diagnostic and therapeutic challenges of EBV-positive mucocutaneous ulcer: a case report and systematic review of the literature. Experimental Hematology & Oncology, 5, 2016, 13.
6. Bunn, B., van Heerden, W., EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV/AIDS. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 120 (2015), 725–732.
7. Satou, A., Kohno, A., Fukuyama, R., et al. EBV-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic post-transplant lymphoproliferative disorder and cytomegalovirus colitis. Human Pathology, 2016, 30192–30197, 10.1016/j.humpath.2016.08.001 [Epub ahead of print] PubMed PMID: 27569297.
8. Nelson, A.A., Harrington, A.M., Kroft, S., et al. Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer. Bone Marrow Transplantation 51 (2016), 300–302.
9. Matnani, R., Peker, D., Azathioprine induced Epstein Barr virus-positive mucocutaneous ulcer arising in perianal fistula and abscess associated with Crohn's disease. Journal of Crohn's and Colitis 8 (2014), 1747–1748.
10. Magalhaes, M., Ghorab, Z., Morneault, J., et al. Age-related Epstein–Barr virus-positive mucocutaneous ulcer: a case report. Clinical Case Reports 3 (2015), 531–534.